Depression is prevalent among elderly adults with aortic stenosis undergoing transcatheter or surgical aortic valve replacement (TAVR or SAVR), and is associated with a higher risk of all-cause mortality, according to the prospective FRAILTY-AVR* cohort study.
A study in the UK recently demonstrated that cardiovascular disease prevention by adhering to statin treatment, improving diet or physical activity levels, reducing alcohol intake and quitting smoking results in fewer psychiatric admissions among mentally ill patients.
A tamper-resistant controlled-release oxycodone formulation reduced tampering with pharmaceutical opioids among people who inject drugs, but had no effect on population-level opioid use or harm, results of the NOMAD study showed.
Severe postnatal depression (PND), especially if persisting up to 11 years after birth, raises the risk of adverse child outcomes such as child behavioural and developmental disturbances, according to a recent study.
The use of an oestradiol patch in addition to oral intermittent micronized progesterone for 1 year helped prevent the development of depressive symptoms in women going through menopause, particularly those in the early stages of the menopause transition, a recent study found.
Depressive symptoms are common in elderly adults undergoing transcatheter (TAVR) or surgical (SAVR) aortic valve replacement, according to a recent study, which also shows that mortality in the short- and midterm is elevated among those with depressive symptoms.
Hormone treatment confers beneficial mood effects in postmenopausal women, according to a recent study, which reports that a transdermal oestradiol plus intermittent micronized progesterone (TE+IMP) treatment regimen is more effective than placebo at reducing depressive symptoms in peri- and postmenopausal women.
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
In males with primary or secondary hypogonadism (HG), adherence to topical testosterone therapy (TTh) appears to improve total testosterone and decrease the risk of conditions associated with HG, a recent study has shown.
Short-term treatment with methotrexate at >0.5 defined daily dose (8.75 mg/week) may help reduce the risk of ischaemic stroke in rheumatoid arthritis (RA) patients, while hydroxychloroquine and sulfasalazine have neutral effects, a retrospective study has found.